Literature DB >> 9837790

No role for pepstatin-A-sensitive acidic proteinases in reovirus infections of L or MDCK cells.

S Kothandaraman1, M C Hebert, R T Raines, M L Nibert.   

Abstract

Strong evidence indicates that virions of mammalian reoviruses undergo proteolytic processing by acid-dependent cellular proteinases as an essential step in productive infection. Proteolytic processing takes the form of a series of cleavages of outer-capsid proteins final sigma3 and mu1/mu1C. Previous studies showed an effect of both NH4Cl and E-64 on these cleavages, indicating that one or more of the acid-dependent cysteine proteinases in mammalian cells (cathepsins B and L, for example) is required; however, these studies did not address whether acid-dependent aspartic proteinases in those cells (cathepsin D, for example) may also be required. To determine the role of aspartic proteinases in reovirus entry, studies with pepstatin A, a specific inhibitor of aspartic proteinases, were performed. The results showed that pepstatin A neither blocks nor slows reovirus infection of L or MDCK cells. Experiments using ribonuclease A and other proteins as cleavable substrates showed that cathepsin-D-like proteinases from these cells are inhibited within the tested range of pepstatin A concentrations both in vitro and within living cells. In other experiments, virion-bound final sigma3 protein was shown to be a poor substrate for cleavage by cathepsin D in vitro, consistent with the findings with inhibitors. In sum, the data indicate that cathepsin-D-like aspartic proteinases provide little or no activity toward proteolytic events required for infection of L or MDCK cells with reovirus virions. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837790     DOI: 10.1006/viro.1998.9434

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3.

Authors:  Judit Jané-Valbuena; Laura A Breun; Leslie A Schiff; Max L Nibert
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Site-specific PEGylation endows a mammalian ribonuclease with antitumor activity.

Authors:  Thomas J Rutkoski; John A Kink; Laura E Strong; Ronald T Raines
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

3.  A single mutation in the carboxy terminus of reovirus outer-capsid protein sigma 3 confers enhanced kinetics of sigma 3 proteolysis, resistance to inhibitors of viral disassembly, and alterations in sigma 3 structure.

Authors:  Gregory J Wilson; Emma L Nason; Charles S Hardy; Daniel H Ebert; J Denise Wetzel; B V Venkataram Prasad; Terence S Dermody
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Transport to late endosomes is required for efficient reovirus infection.

Authors:  Bernardo A Mainou; Terence S Dermody
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

5.  Thermolabilizing pseudoreversions in reovirus outer-capsid protein micro 1 rescue the entry defect conferred by a thermostabilizing mutation.

Authors:  Melina A Agosto; Jason K Middleton; Elaine C Freimont; John Yin; Max L Nibert
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

6.  Secretory ribonucleases are internalized by a dynamin-independent endocytic pathway.

Authors:  Marcia C Haigis; Ronald T Raines
Journal:  J Cell Sci       Date:  2003-01-15       Impact factor: 5.285

7.  Adaptation of reovirus to growth in the presence of protease inhibitor E64 segregates with a mutation in the carboxy terminus of viral outer-capsid protein sigma3.

Authors:  D H Ebert; J D Wetzel; D E Brumbaugh; S R Chance; L E Stobie; G S Baer; T S Dermody
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

8.  In vitro recoating of reovirus cores with baculovirus-expressed outer-capsid proteins mu1 and sigma3.

Authors:  K Chandran; S B Walker; Y Chen; C M Contreras; L A Schiff; T S Baker; M L Nibert
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

9.  Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein micro 1 mediates membrane disruption.

Authors:  Kartik Chandran; Diane L Farsetta; Max L Nibert
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Fluorogenic label to quantify the cytosolic delivery of macromolecules.

Authors:  Tzu-Yuan Chao; Ronald T Raines
Journal:  Mol Biosyst       Date:  2013-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.